Nature | Biotechnology
Follow
Editor’s pick: Gate Bioscience
Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year. Gate Bioscience wants to tailor gates that stop problematic proteins at the source.
